astrazeneca plc-spons adr (AZN:New York)
Earnings & Estimates Summary - ASTRAZENECA PLC-SPONS ADR (AZN)
2013 revenues at AstraZeneca PLC totaled $25.7B USD, while annual earnings equaled $5.05 per share.
Quarterly Earnings & Estimates - ASTRAZENECA PLC-SPONS ADR (AZN)
AstraZeneca PLC's Quarterly Earnings
AstraZeneca PLC reported 1st quarter 2014 earnings of $1.17 per share on 04/26/2014.
Annual Earnings & Estimates - ASTRAZENECA PLC-SPONS ADR (AZN)
AstraZeneca PLC's Annual Earnings
AstraZeneca PLC reported annual 2013 earnings of $5.05 per share on 02/8/2014.
Quarterly Revenues - ASTRAZENECA PLC-SPONS ADR (AZN)
AstraZeneca PLC's Quarterly Revenues
AstraZeneca PLC had 1st quarter 2014 revenues of $6.4B USD. This bettered the $6.4B USD consensus of the 17 analysts covering the company. This was 0.5% above the prior year's 1st quarter results.
Annual Revenues - ASTRAZENECA PLC-SPONS ADR (AZN)
AstraZeneca PLC's Annual Revenues
AstraZeneca PLC had revenues for the full year 2013 of $25.7B USD. This was -8.1% below the prior year's results.
|AbbVie Inc||$54.96 USD||-0.83|
|Bayer AG||€101.21 EUR||0.00|
|Biogen Idec Inc||$322.22 USD||+3.10|
|Bristol-Myers Squibb Co||$48.62 USD||+0.11|
|Novo Nordisk A/S||kr247.80 DKK||0.00|
|View Industry Companies|